STAT3 and plasma cell myeloma: In multiple myeloma, CaMKIIγ is frequently up-regulated and maintains STAT3 and ERK signaling; gain- and loss-of-function studies demonstrate dependence on CaMKIIγ, and berbamine analogs show preclinical efficacy against CaMKIIγ-positive xenografts [68].